The MarketWatch News Department was not involved in the creation of this content. The investigational device evaluated in the trial, previously known as the GORE(R) VIAFORT Vascular Stent, will now be ...

July 15, 2005 — The U.S. Food and Drug Administration (FDA) has approved single- and dual-chamber versions of an implantable cardioverter defibrillator that feature managed ventricular pacing and ...

New device size comes in response to physicians’ requests for additional offerings to expand treatment options FLAGSTAFF, Ariz.,W. L. Gore & Associates (Gore) today announced the availability of a new ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) is celebrating the 20 th anniversary of the introduction of the GORE® VIABAHN® Endoprosthesis, the market-leading stent-graft ...

FLAGSTAFF, Ariz., W. L. Gore & Associates (Gore) announces that the first patients are now enrolled in the Gore RELINE MAX Clinical Study, a post-approval study to continue to evaluate the GORE® ...

Please provide your email address to receive an email when new articles are posted on . The U.S Food and Drug Administration has granted indication for the Viabahn Endoprosthesis, made by W. L. Gore & ...

Improvements to large diameter devices include accessibility through smaller sheaths while providing enhanced visualization by adding radiopaque markers 25 years of continued innovation PUTZBRUNN, ...

W. L. Gore & Associates, Inc. (Gore) hat für die Endoprothese GORE® VIABAHN® zur Verbesserung der Durchblutung beim symptomatischen Verschluss peripherer Venen mit Ausnahme der Hohl- und Lungenvenen ...

The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...

The GORE VIABAHN Endoprosthesis portfolio spans a wide variety of sizes, including the recently added 7.5 cm and 25 cm length versions, the industry’s longest such device. The dynamic range of options ...